Cargando…

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice

Overactive bladder (OAB) is a common condition that affects a significant patient population. The N-methyl-D-aspartate receptor (NMDAR) has a role in developing bladder overactivity, pharmacological inhibition of which inhibits bladder overactivity. The common pathogenesis of OAB involves bladder sm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xiang, Luo, Chuang, Liang, Jia Yu, Huang, Run, Yang, Jia Li, Li, Linlong, Li, YangYang, Xing, Hongming, Chen, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272467/ https://www.ncbi.nlm.nih.gov/pubmed/34277150 http://dx.doi.org/10.7717/peerj.11684

Ejemplares similares

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015)

The immune responses to different Uropathogens call individual interventions for bladder infection
por: Li, Linlong, et al.
Publicado: (2022)

Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
por: Tran, Khanh, et al.
Publicado: (2009)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
por: Liao, Kuang-Ming, et al.
Publicado: (2022)

Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life
por: Jayarajan, Jyotsna, et al.
Publicado: (2013)

Evaluation of mouse urinary bladder smooth muscle for diurnal differences in contractile properties
por: White, Rachel S., et al.
Publicado: (2015)

Effects of hypoxia and glucose-removal condition on muscle contraction of the smooth muscles of porcine urinary bladder
por: NAGAI, Yuta, et al.
Publicado: (2015)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses
por: Michel, Martin C., et al.
Publicado: (2022)

Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patients
por: Müderrisoglu, A. Elif, et al.
Publicado: (2023)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Activation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptoms
por: Zhai, Kui, et al.
Publicado: (2016)

Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Liao, Limin, et al.
Publicado: (2022)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Phorbol 12,13-Dibutyrate-Induced, Protein Kinase C-Mediated Contraction of Rabbit Bladder Smooth Muscle
por: Wang, Tanchun, et al.
Publicado: (2012)

Daidzein is the in vivo active compound of Puerariae Lobatae Radix water extract for muscarinic receptor-3 inhibition against overactive bladder
por: Qiang, Yining, et al.
Publicado: (2022)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Pharmacotherapy for Pediatric Neurogenic Bladder
por: Kroll, Paweł
Publicado: (2017)

Spheroids of Bladder Smooth Muscle Cells for Bladder Tissue Engineering
por: Gerwinn, Tim, et al.
Publicado: (2021)

Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer
por: Wei, Wei, et al.
Publicado: (2018)

AB195. Correlations among improvements in overactive bladder symptom scores (OABSS) and urinary nerve growth factor levels in overactive bladder patients
por: Yang, Bo
Publicado: (2016)

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder
por: Chung, Maurice K., et al.
Publicado: (2010)

Effect of caffeine on bladder function in patients with overactive bladder symptoms
por: Lohsiriwat, Supatra, et al.
Publicado: (2011)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
por: Gong, Qin-Qin, et al.
Publicado: (2020)

The surgical effect on overactive bladder symptoms in women with pelvic organ prolapse
por: Wu, Ling-Ying, et al.
Publicado: (2021)

Mechanism of traditional Chinese medicine in treating overactive bladder
por: Liao, Yuxiang, et al.
Publicado: (2022)

Telmisartan inhibits bladder smooth muscle fibrosis in neurogenic bladder rats
por: Liu, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o6tuq9sapdp0jbk1j80dqgrami